ctrl K

MoonLake Immunotherapeuti... (MLTX)

NASDAQ: MLTX · Real-Time Price · USD

40.18

1.03 (2.63%)

At close: Apr 29, 2025, 3:59 PM

39.51

-1.67%

Pre-market: Apr 30, 2025, 04:08 AM EDT

MoonLake Immunotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	13.16K	12.36K	4.97K	n/a
Gross Profit	n/a	-13.16K	-12.36K	-4.97K	n/a
Operating Income	n/a	-54.12M	-65.06M	-53.58M	-105.76K
Interest Income	n/a	n/a	n/a	n/a	14.92K
Pretax Income	-120.96B	-43.98M	-64.47M	-53.64M	-90.84K
Net Income	-120.68B	-36.01M	-64.51M	-53.64M	-90.84K
Selling & General & Admin	30.32B	22.32M	23.01M	18.05M	105.75K
Research & Development	112.77B	31.79M	42.05M	35.52M	n/a
Other Expenses	n/a	n/a	591.73K	n/a	n/a
Operating Expenses	143.09B	54.12M	65.06M	53.57M	105.75K
Interest Expense	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	18.03M	n/a
Cost & Expenses	n/a	54.12M	65.06M	53.58M	105.75K
Income Tax Expense	-282.2M	94.39K	36.37K	4.75K	-206.3K
Shares Outstanding (Basic)	62.87M	49.12M	29.36M	7.84M	14.8M
Shares Outstanding (Diluted)	62.87M	49.12M	29.36M	7.84M	14.8M
EPS (Basic)	-1.92K	-0.73	-2.2	-6.84	-0.01
EPS (Diluted)	-1.92K	-0.73	-2.2	-6.84	-0.01
EBITDA	n/a	-54.11M	-65.05M	-53.63M	-90.84K
EBIT	n/a	-54.12M	-65.06M	-53.64M	-90.84K
Depreciation & Amortization	n/a	13.16K	12.36K	4.97K	206.3K